• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . Microbiota-derived inosine programs protective CD8+ T cell responses against influenza in newborns

tetano

Editor, Senior Moderator
Cell


. 2025 Jun 3:S0092-8674(25)00563-X.
doi: 10.1016/j.cell.2025.05.013. Online ahead of print. Microbiota-derived inosine programs protective CD8[SUP]+[/SUP] T cell responses against influenza in newborns

Joseph Stevens[SUP] 1 [/SUP], Erica Culberson[SUP] 1 [/SUP], Jeremy Kinder[SUP] 2 [/SUP], Alicia Ramiriqui[SUP] 3 [/SUP], Jerilyn Gray[SUP] 3 [/SUP], Madeline Bonfield[SUP] 4 [/SUP], Tzu-Yu Shao[SUP] 2 [/SUP], Faris Al Gharaibeh[SUP] 5 [/SUP], Laura Peterson[SUP] 5 [/SUP], Shelby Steinmeyer[SUP] 6 [/SUP], Emily M Eshleman[SUP] 7 [/SUP], Shikha Negi[SUP] 7 [/SUP], William Zacharias[SUP] 8 [/SUP], Gloria Pryhuber[SUP] 9 [/SUP], Oindrila Paul[SUP] 10 [/SUP], Shaon Sengupta[SUP] 10 [/SUP], Theresa Alenghat[SUP] 7 [/SUP], Sing Sing Way[SUP] 2 [/SUP], Hitesh Deshmukh[SUP] 11 [/SUP]



Affiliations
Abstract

Early-life susceptibility to respiratory viral infections remains a major public health concern, yet the underlying mechanisms are poorly understood. We demonstrate that antibiotic-induced dysbiosis impairs influenza-specific CD8[SUP]+[/SUP] T cell immunity in infant mice and humans through the disruption of nuclear factor interleukin 3 (NFIL3)-dependent T cell programming. Mechanistically, we show that dysbiosis reduces intestinal and circulating inosine levels, disrupting NFIL3's epigenetic regulation of T cell factor 1 (TCF1) expression. This leads to intrinsic defects in CD8[SUP]+[/SUP] T cell proliferation and differentiation, diminished effector responses, and impaired formation of tissue-resident memory cells. Bifidobacterium colonization restores intestinal and pulmonary inosine levels, establishing a specific pathway of gut-lung metabolic communication. Notably, inosine supplementation rescues NFIL3-dependent regulation of TCF1, enhancing CD8[SUP]+[/SUP] T cell responses and protection against influenza infection in dysbiotic infants. Our findings reveal how early-life microbial communities shape antiviral immunity and identify inosine as a therapeutic target for enhancing respiratory defenses in infants.

Keywords: T cell responses; immunology; infants; influenza; inosine; microbiota.

 
Back
Top